SEARCH:

News for Food and Drug Administration (FDA)

News > FDA

Listings 211 - 220 of 441:

96% of U.S. Banks Failing to Implement FFIEC Multi-Factor Authentication: Study
A study released last month by Sestus Data Company and BearingPoint Financial Services Information Security Group reports 96% of U.S. banks are failin...

EFSA and FDA Strengthen Cooperation in Food Safety Science
The European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) today signed the first U.S./European agreement in the area o...

FDA Finds Consumers Continue to Buy Potentially Risky Drugs Over the Internet
The U.S. Food and Drug Administration continues to warn the American public about the dangers of buying medications over the Internet. New data col...

New Pocket Guides Enable Rapid Mastery Of IT Governance And U.S. And U.K. Regulatory Frameworks
The total reliance of today’s businesses on technology, coupled with a climate of ever-growing regulation, has placed IT governance amongst the most p...

FDA Approves LISTEX P100 as GRAS for all Food Products
In the fight against Listeria, one of the most dangerous food pathogens, US food processing companies can now apply a novel yet natural tool: LISTEX b...

FDA Clears 'Computerized Medication Box' For U.S. Market
The U.S. Food and Drug Administration has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable...

FDA Issues Dietary Supplements Final Rule
he U.S. Food and Drug Administration recently announced a final rule establishing regulations to require current good manufacturing practices (cGMP) f...

First Drug For Treating Fibromyalgia Gets FDA Approval
The U.S. Food and Drug Administration recently approved Lyrica (pregabalin), the first drug to treat fibromyalgia, a disorder characterized by pain, f...

New Orphan Drug For Treatment Of Pulmonary Arterial Hypertension Gets FDA Approval
The U.S. Food and Drug Administration (FDA) approved Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension, a rare, life-threate...

Alseres Pharmaceuticals Announces FDA Clearance To Increase Dose Level In Cethrin Phase I/IIa Clinical Trial For Acute Spinal Cord Injury
Alseres Pharmaceuticals, formerly Boston Life Sciences, announced that the U.S. Food and Drug Administration (FDA) has authorized an increase in the d...

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next

Get Free Security Resources from Symantec